Scholarlink

Background <p>For heavy current and former smokers aged 50–75&#xa0;years, low-dose computed tomography (LD-CT) for early detection of lung cancer will be offered as a&#xa0;regular benefit by statutory health insurances in Germany as from 2026.</p> Objective <p>The evidence, risks, requirements, procedure and implementation of the lung cancer screening program including the current status are presented.</p> Material and methods <p>This article gives a summary of current data and reports on early detection of lung cancer using LD-CT and a description of the planned implementation of the lung cancer screening program.</p> Results <p>The systematic analysis of randomized controlled trials for early detection of lung cancer using LD-CT by the Institute for Quality and Efficiency in the Healthcare system (IQWiG) concluded that the risk of dying from lung cancer can be reduced by LD-CT screening. The legal basis for the eligibility to obtain LD-CT-screening within the lung cancer screening program is already covered by the Lung Cancer Screening Ordinance. The mandatory offer of a&#xa0;smoking cessation program is linked to the lung cancer screening by LD-CT.</p> Conclusion <p>The implementation of the lung cancer screening using LD-CT is expected to start in April 2026 onwards, a&#xa0;milestone for cancer prevention in Germany. The expected effect of the systematic screening program remains to be confirmed after the successful, nationwide introduction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lungenkrebsfrüherkennung in Deutschland – ab April 2026 eine kassenärztliche Leistung

  • 期刊论文

  • 发表日期：

    2026年4月1日

查看全文
  • Iris Watermann,
  • Anton Faron,
  • Marlen Szewczyk,
  • Christopher Wirks,
  • Martin Reck

摘要

Background

For heavy current and former smokers aged 50–75 years, low-dose computed tomography (LD-CT) for early detection of lung cancer will be offered as a regular benefit by statutory health insurances in Germany as from 2026.

Objective

The evidence, risks, requirements, procedure and implementation of the lung cancer screening program including the current status are presented.

Material and methods

This article gives a summary of current data and reports on early detection of lung cancer using LD-CT and a description of the planned implementation of the lung cancer screening program.

Results

The systematic analysis of randomized controlled trials for early detection of lung cancer using LD-CT by the Institute for Quality and Efficiency in the Healthcare system (IQWiG) concluded that the risk of dying from lung cancer can be reduced by LD-CT screening. The legal basis for the eligibility to obtain LD-CT-screening within the lung cancer screening program is already covered by the Lung Cancer Screening Ordinance. The mandatory offer of a smoking cessation program is linked to the lung cancer screening by LD-CT.

Conclusion

The implementation of the lung cancer screening using LD-CT is expected to start in April 2026 onwards, a milestone for cancer prevention in Germany. The expected effect of the systematic screening program remains to be confirmed after the successful, nationwide introduction.